Tel:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@anticorps-enligne.fr

CDKN2B anticorps (AA 1-130)

CDKN2B Reactivité: Souris WB, IHC, ICC, IP Hôte: Lapin Polyclonal unconjugated
N° du produit ABIN5013417
  • Antigène Voir toutes CDKN2B Anticorps
    CDKN2B (Cyclin-Dependent Kinase Inhibitor 2B (p15, Inhibits CDK4) (CDKN2B))
    Épitope
    • 13
    • 12
    • 9
    • 8
    • 7
    • 6
    • 5
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    AA 1-130
    Reactivité
    • 66
    • 16
    • 15
    • 4
    • 2
    • 2
    • 1
    • 1
    • 1
    Souris
    Hôte
    • 57
    • 9
    • 1
    Lapin
    Clonalité
    • 59
    • 8
    Polyclonal
    Conjugué
    • 31
    • 7
    • 7
    • 6
    • 5
    • 5
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    Cet anticorp CDKN2B est non-conjugé
    Application
    • 55
    • 43
    • 37
    • 35
    • 25
    • 14
    • 6
    • 4
    • 1
    Western Blotting (WB), Immunohistochemistry (IHC), Immunocytochemistry (ICC), Immunoprecipitation (IP)
    Fonction
    Polyclonal Antibody to Cyclin Dependent Kinase Inhibitor 2B (CDKN2B)
    Specificité
    The antibody is a rabbit polyclonal antibody raised against CDKN2B. It has been selected for its ability to recognize CDKN2B in immunohistochemical staining and western blotting.
     Réactivité croisée
    Humain, Rat
    Purification
    Antigen-specific affinity chromatography followed by Protein A affinity chromatography
    Immunogène
    Recombinant Cyclin Dependent Kinase Inhibitor 2B (CDKN2B) corresdonding to Met1~Asp130 with N-terminal His Tag
    Isotype
    IgG
    Top Product
    Discover our top product CDKN2B Anticorps primaire
  • Indications d'application

    Western blotting: 0.5-2 μg/mL Immunocytochemistry in formalin fixed cells: 5-20 μg/mL Immunohistochemistry in formalin fixed frozen section: 5-20 μg/mL Immunohistochemistry in paraffin section: 5-20 μg/mL Enzyme-linked Immunosorbent Assay: 0.05-2 μg/mL Optimal working dilutions must be determined by end user.

    Commentaires

    The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37°C for 48h, and no obvious degradation and precipitation were observed. The loss rate is less than 5% within the expiration date under appropriate storage condition.

    Restrictions
    For Research Use only
  • Format
    Liquid
    Concentration
    Lot specific
    Buffer
    PBS, pH 7.4, containing 0.02 % Sodium azide, 50 % glycerol.
    Agent conservateur
    Sodium azide
    Stock
    4 °C,-20 °C
    Stockage commentaire
    Store at 4°C for frequent use. Stored at -20°C in a manual defrost freezer for two year without detectable loss of activity. Avoid repeated freeze-thaw cycles.
    Date de péremption
    24 months
  • Antigène
    CDKN2B (Cyclin-Dependent Kinase Inhibitor 2B (p15, Inhibits CDK4) (CDKN2B))
    Autre désignation
    Cyclin Dependent Kinase Inhibitor 2B (CDKN2B Produits)
    Synonymes
    anticorps p14-INK4b, anticorps cdk4l, anticorps ink4b, anticorps mts2, anticorps p15, anticorps p15ink4b, anticorps tp15, anticorps CDK4I, anticorps INK4B, anticorps MTS2, anticorps P15, anticorps TP15, anticorps p15INK4b, anticorps AV083695, anticorps INK4b, anticorps p15(INK4b), anticorps CDKN2A, anticorps cyclin dependent kinase inhibitor 2B, anticorps Cyclin-dependent kinase 4 inhibitor B, anticorps cyclin-dependent kinase inhibitor 2B, anticorps cyclin-dependent kinase inhibitor 2B L homeolog, anticorps cyclin-dependent kinase inhibitor 2B (p15, inhibits CDK4), anticorps CDKN2B, anticorps cdn2b, anticorps cdkn2b, anticorps cdkn2b.L, anticorps Cdkn2b
    Sujet
    P15, INK4B, MTS2, TP15, Cyclin-dependent kinase 4 inhibitor B, Multiple tumor suppressor 2
    Pathways
    Cycle Cellulaire, Mitotic G1-G1/S Phases
Vous êtes ici:
Support technique